Investor Contact

InnerScope Hearing Technologies
2151 Professional Drive, 2nd Floor
Roseville, CA., 95661

Phone:
916-218-4100

Email:
info@innd.com

Overview

InnerScope Hearing Technologies seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. InnerScope Hearing Technologies is traded on the OTC under the ticker symbol INND.

About

InnerScope Hearing Technologies as a manufacturer, distributor and retailer of “Self-Fitting” FDA-Registered Hearing Aids, “Self-Fitting” Personal Sound Amplifiers Products, Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing & Tinnitus Supplements, proprietary CBD Oil for Tinnitus and assorted Ear & Hearing Aid Related Products (collectively “Hearing Products”) is on a mission to improve the quality of life of the more than 1.2 billion people worldwide who suffer from hearing impairment and hearing related issues. As a rapidly expanding consolidator of the hearing aid industry, the management team of InnerScope is applying decades of industry experience, as well as new technology, to provide affordable FDA registered hearing aids and personal sound amplification products directly to the consumer. InnerScope products are available on Walmart.com, Sears.com and other retailers and pharmacy chains nationwide. InnerScope believes it is well positioned to benefit from the “Over the Counter Hearing Aid Act, which is designed to enable adults with perceived mild-to-moderate hearing loss to access Over the Counter hearing aids without being seen by a hearing care professional.

InnerScope also operates a chain of Audiological Retail Clinics and plans to continue to open, acquire additional locations of audiological and retail hearing aid clinics. InnerScope’ mission is to serve the approximately 60 million people in North America and 1.2 billion people worldwide who are suffering with mild to profound hearing loss.

INND
OTC

VOLUME
CHANGE